| 1 |
2020 |
Antibiotic Resistance of Viridans Group Streptococci Isolated from Dental Plaques. |
MICs |
| 2 |
2020 |
Antimicrobial Activity of Telavancin Tested In Vitro Against a Global Collection of Gram-Positive Pathogens, Including Multidrug-Resistant Isolates (2015-2017). |
BHS, CLSI, MRSA |
| 3 |
2020 |
Differentiation between Streptococcus pneumoniae and other viridans group streptococci by matrix-assisted laser desorption/ionization time of flight mass spectrometry. |
CI, MALDI-TOF MS |
| 4 |
2020 |
Incidence of infective endocarditis caused by viridans group streptococci in Sweden - effect of cessation of antibiotic prophylaxis in dentistry for risk individuals. |
IE |
| 5 |
2020 |
Pathogen influence on epidemiology, diagnostic evaluation and management of infective endocarditis. |
IE |
| 6 |
2020 |
Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes. |
FN, GN, GP, IDSA, OR |
| 7 |
2020 |
Strain-Specific Adaptations of Streptococcus mitis-oralis to Serial In Vitro Passage in Daptomycin (DAP): Genotypic and Phenotypic Characteristics. |
CL, DAP, DAP-R, IE, PA, PG, SNPs |
| 8 |
2019 |
Activity of tedizolid against gram-positive clinical isolates causing infections in Europe and surrounding areas (2014-2015). |
--- |
| 9 |
2019 |
An Analysis of Resistance Patterns of Oral Streptococci Obtained from Orofacial Infections Against Beta-lactams, Clindamycin and Vancomycin over 2014-2018. |
AST |
| 10 |
2019 |
Antimicrobial activity of dalbavancin tested against Gram-positive organisms isolated from patients with infective endocarditis in US and European medical centres. |
--- |
| 11 |
2019 |
Be careful about MICs to amoxicillin for patients with Streptococci-related infective endocarditis. |
BGS, CI, IE, IQR, MICs |
| 12 |
2019 |
Cumulative incidence and mortality of infective endocarditis in Siriraj hospital-Thailand: a 10-year retrospective study. |
DM, DRIE, ESRD, IE, MSSA, NVE, PVE |
| 13 |
2019 |
Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis/oralis in an Ex Vivo Simulated Endocarditis Vegetation Model. |
CRO, DAP, DAP-R, DAP-S, IE, PK/PD, SEVs |
| 14 |
2019 |
Endocarditis Caused by Highly Penicillin-Resistant Viridans Group Streptococci: Still Room for Vancomycin-Based Regimens. |
EE, HLDR, IE, PenR |
| 15 |
2019 |
Epidemiological and clinical characteristics of Streptococcus tigurinus endocarditis. |
--- |
| 16 |
2019 |
Mutations in cdsA and pgsA Correlate with Daptomycin Resistance in Streptococcus mitis and S. oralis. |
DAP |
| 17 |
2019 |
Variants of the bile: solubility test to differentiate Streptococcus pneumoniae from other viridans group streptococci. |
--- |
| 18 |
2019 |
[Identification and antibiotic susceptibility of viridans group streptococci isolates recovered from patients hospitalized at a teaching hospital in Buenos Aires City]. |
--- |
| 19 |
2018 |
Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015-16. |
ABSSSIs, BHS, GPC |
| 20 |
2018 |
Acute Streptococcus mitis Sacroiliitis in a Teenager with Unclear Source of Bacteremia: A Case Report and Literature Review. |
--- |
| 21 |
2018 |
Assessment of periodontitis and its role in viridans streptococcal bacteremia and infective endocarditis. |
IE |
| 22 |
2018 |
Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016). |
BHS, BJI, CoNS, MIC |
| 23 |
2018 |
Epidemiology, Clinical Features, and Outcome of Infective Endocarditis due to Abiotrophia Species and Granulicatella Species: Report of 76 Cases, 2000-2015. |
ABI, GRA, HACEK, IE |
| 24 |
2018 |
Profile of Infective Endocarditis: At a Tertiary Care Referral Centre. |
IE, RHD |
| 25 |
2018 |
Rare but Not Infrequent: Infective Endocarditis Caused by Abiotrophia defectiva. |
NVS |
| 26 |
2018 |
Risk Factors for Viridans Group Streptococcal Bacteremia in Neutropenic and Non-neutropenic Patients: A Single Center Case-Case-Control Study. |
CI, OR |
| 27 |
2018 |
Surgically Treated Community-Acquired Brain Abscess: Bacteriological Analysis Based on Predisposing Infections. |
--- |
| 28 |
2018 |
The clinical impact of patients with bloodstream infection with different groups of Viridans group streptococci by using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). |
MALDI-TOF MS |
| 29 |
2017 |
Activity of dalbavancin tested against Gram-positive clinical isolates causing skin and skin-structure infections in paediatric patients from US hospitals (2014-2015). |
BHS, CoNS, MRSA, SSSIs |
| 30 |
2017 |
Impact of AHA's 2007 guideline change on incidence of infective endocarditis in infants and children. |
AHA, IE, NIS |
| 31 |
2017 |
Prevalence of macrolide-lincosamide resistance and multidrug resistance phenotypes in streptococcal isolates causing infections in European hospitals: Evaluation of the in vitro activity of oritavancin and comparator agents. |
BHS, MDR, MIC |
| 32 |
2017 |
[Comparison of MALDI-TOF and 16S rRNA methods in identification of viridans group streptococci]. |
--- |
| 33 |
2016 |
A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology Group. |
AML, aRR |
| 34 |
2016 |
Antibodies Targeting Hsa and PadA Prevent Platelet Aggregation and Protect Rats against Experimental Endocarditis Induced by Streptococcus gordonii. |
IE |
| 35 |
2016 |
Antimicrobial susceptibility against penicillin, ampicillin and vancomycin of viridans group Streptococcus in oral microbiota of patients at risk of infective endocarditis. |
IE |
| 36 |
2016 |
Association of oral flora with orbital complications of acute sinusitis. |
--- |
| 37 |
2016 |
Ceftaroline activity tested against viridans group streptococci from US hospitals. |
MALDI-TOF |
| 38 |
2016 |
Complete Genome Sequence of Streptococcus mitis Strain SVGS_061 Isolated from a Neutropenic Patient with Viridans Group Streptococcal Shock Syndrome. |
--- |
| 39 |
2016 |
Effect of Periodontal Therapy With Amoxicillin-Metronidazole on Pharyngeal Carriage of Penicillin- and Erythromycin-Resistant Viridans Streptococci. |
MIC |
| 40 |
2016 |
In vitro activity of dalbavancin against multidrug-resistant Staphylococcus aureus and streptococci from patients with documented infections in Europe and surrounding regions (2011-2013). |
FDA, MDR, MRSA |
| 41 |
2016 |
In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients. |
MRSA, TMP/SMX |
| 42 |
2016 |
Pronounced heterogeneity observed in high-level daptomycin-resistant viridans group streptococci. |
HLDR |
| 43 |
2016 |
Rare and unusual isolates of viridans streptococci from the human oral cavity. |
--- |
| 44 |
2016 |
The causative agents in infective endocarditis: a systematic review comprising 33,214 cases. |
CoNS, IE |
| 45 |
2016 |
Using Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) Complemented with Selected 16S rRNA and gyrB Genes Sequencing to Practically Identify Clinical Important Viridans Group Streptococci (VGS). |
MALDI-TOF |
| 46 |
2016 |
Viridans Group Streptococcal Infections in Children After Chemotherapy or Stem Cell Transplantation: A 10-year Review From a Tertiary Pediatric Hospital. |
VGSB |
| 47 |
2015 |
Characterization of high-level daptomycin resistance in Viridans group Streptococci developed upon in vitro exposure to daptomycin. |
HLDR |
| 48 |
2015 |
Clinical Significance and Characterization of Streptococcus tigurinus Isolates in an Adult Population. |
MALDI-TOF MS |
| 49 |
2015 |
Comparison of antibiotic susceptibility in viridans group streptococci in low and high antibiotic-prescribing General Practices. |
GP |
| 50 |
2015 |
Febrile neutropenia in children treated for malignancy. |
BSI, CDR, FN, IFI, MDR |
| 51 |
2015 |
Incidence of Infective Endocarditis Due to Viridans Group Streptococci Before and After the 2007 American Heart Association's Prevention Guidelines: An Extended Evaluation of the Olmsted County, Minnesota, Population and Nationwide Inpatient Sample. |
AHA, IE |
| 52 |
2015 |
Species-specific difference in antimicrobial susceptibility among viridans group streptococci. |
--- |
| 53 |
2015 |
Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancin. |
ABSSSIs, BHS, CA, DAL, USA, VAN |
| 54 |
2015 |
Use of in vitro vancomycin testing results to predict susceptibility to oritavancin, a new long-acting lipoglycopeptide. |
BHS, CoNS, ENT |
| 55 |
2015 |
Viridans Group Streptococci clinical isolates: MALDI-TOF mass spectrometry versus gene sequence-based identification. |
MALDI-TOF MS |
| 56 |
2014 |
Development and validation of a clinical model to predict the presence of beta-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients. |
BSI, MIC |
| 57 |
2014 |
Effective oral health in infective endocarditis: efficacy of high-street mouthwashes against the viridans group streptococci. |
IE, NCTC |
| 58 |
2014 |
Genetic determinants and elements associated with antibiotic resistance in viridans group streptococci. |
--- |
| 59 |
2014 |
GyrB polymorphisms accurately assign invasive viridans group streptococcal species. |
gyrB, MLSA |
| 60 |
2014 |
Identification and characterization of catheter-related bloodstream infections due to viridans group streptococci in patients with cancer. |
BSI |
| 61 |
2014 |
In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients. |
CoNS, MICs, MR, MRSA, MS, MSSA |
| 62 |
2014 |
Predictors and outcomes of viridans group streptococcal infections in pediatric acute myeloid leukemia: from the Canadian infections in AML research group. |
AML, CI, OR, VSSS |
| 63 |
2014 |
Species-level assessment of the molecular basis of fluoroquinolone resistance among viridans group streptococci causing bacteraemia in cancer patients. |
MLSA, QRDRs |
| 64 |
2014 |
Streptococcus mitis strains causing severe clinical disease in cancer patients. |
--- |
| 65 |
2014 |
The Role of Corticosteroids in Adult Respiratory Distress Syndrome caused by Viridans Group Streptococci Bacteremia in Neutropenic Patients. |
ARDS |
| 66 |
2013 |
Comparative Genomic Analyses of Streptococcus pseudopneumoniae Provide Insight into Virulence and Commensalism Dynamics. |
SPPN |
| 67 |
2013 |
Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin. |
HLDR |
| 68 |
2013 |
High frequency of streptococcal bacteraemia during childhood AML therapy irrespective of dose of cytarabine. |
NOPHO |
| 69 |
2013 |
Population structure and characterization of viridans group streptococci (VGS) isolated from the upper respiratory tract of patients in the community. |
AR |
| 70 |
2013 |
Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010). |
AWARE, cSSTIs, MRSA, MSSA |
| 71 |
2013 |
Spectrum of gram-positive bacteraemia and in vitro activities of daptomycin, linezolid and vancomycin against organisms isolated from cancer patients. |
CoNS |
| 72 |
2013 |
Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011). |
betaHS, DAL, DAP, SA, VAN |
| 73 |
2013 |
Value of matrix-assisted laser desorption ionization-time of flight for routine identification of viridans group streptococci causing bloodstream infections. |
MALDI-TOF |
| 74 |
2012 |
Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association's endocarditis prevention guidelines. |
IE |
| 75 |
2012 |
Phenotypic and genotypic characterization of Thai oral streptococci, lactobacilli and pediococci. |
Group I |
| 76 |
2011 |
Bacterial contamination of Saudi "one" Riyal paper notes. |
--- |
| 77 |
2011 |
Comparasion of five gene loci (rnpB, 16S rRNA, 16S-23S rRNA, sodA and dnaJ) to aid the molecular identification of viridans-group streptococci and pneumococci. |
--- |
| 78 |
2011 |
Comparison of minimum inhibitory concentration by broth microdilution testing versus standard disc diffusion testing in the detection of penicillin, erythromycin and ciprofloxacin resistance in viridans group streptococci. |
--- |
| 79 |
2011 |
Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study. |
IE, OPAT, S. aureus, S. bovis |
| 80 |
2011 |
Evaluation of the MicroScan MICroSTREP plus antimicrobial panel for testing beta-hemolytic streptococci and viridans group streptococci. |
BHS, CA, MICs |
| 81 |
2011 |
Identification of clinically relevant viridans group streptococci by phenotypic and genotypic analysis. |
MLSA, RFLP |
| 82 |
2011 |
Misidentification of alpha-hemolytic streptococci by routine tests in clinical practice. |
DBP, MALDI-TOF MS, MLSA |
| 83 |
2011 |
Molecular characterisation of the quinolone resistance-determining region (QRDR) of the parC gene locus in viridans-group streptococci. |
MIC, QRDR |
| 84 |
2011 |
Molecular characterization and phylogenetic analysis of quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and parE gene loci in viridans group streptococci isolated from adult patients with cystic fibrosis. |
CF, QRDRs |
| 85 |
2011 |
Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF). |
CF, MIC |
| 86 |
2011 |
Prevalence of clustered regulatory interspaced short palindromic repeat (CRISPR)-like sequences in mitis-group streptococci. |
Cas, CRISPR, CRISPRs, PCR |
| 87 |
2011 |
The role of streptococcal plasmin(ogen) binding in infective endocarditis. |
--- |
| 88 |
2011 |
Whole-genome sequence of Streptococcus pseudopneumoniae isolate IS7493. |
--- |
| 89 |
2010 |
Antibiotic susceptibility and resistance of the odontogenic microbiological spectrum and its clinical impact on severe deep space head and neck infections. |
--- |
| 90 |
2010 |
It's not easy being green: the viridans group streptococci, with a focus on pediatric clinical manifestations. |
MALDI-TOF, SAG |
| 91 |
2010 |
[Classical and new approaches in laboratory diagnosis of viridans streptococci]. |
--- |
| 92 |
2009 |
Denaturing gradient gel electrophoresis of PCR-amplified gki genes: a new technique for tracking streptococci. |
DGGE, ERIC-PCR, gki |
| 93 |
2009 |
In vitro inferiority of ceftazidime compared with other beta-lactams for viridans group Streptococcus bacteremia in pediatric oncology patients: implications for antibiotic choices. |
--- |
| 94 |
2009 |
Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF). |
CF |
| 95 |
2009 |
[Enterococcal endocarditis: a multicenter study of 76 cases]. |
IE, LSIE |
| 96 |
2008 |
Identification of species of viridans group streptococci in clinical blood culture isolates by sequence analysis of the RNase P RNA gene, rnpB. |
--- |
| 97 |
2008 |
Pediatric infective endocarditis: Has Staphylococcus aureus overtaken viridans group streptococci as the predominant etiological agent? |
IE |
| 98 |
2008 |
Phylogenetic analysis of viridans group streptococci causing endocarditis. |
--- |
| 99 |
2007 |
Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic viridans group streptococci in a tertiary Korean hospital. |
MICs, PCR |
| 100 |
2007 |
Effects of tigecycline, linezolid and vancomycin on biofilms of viridans streptococci isolates from patients with endocarditis. |
MIC, OD, ODR |
A Search Service for Abbreviation / Long Form
